---
title: "Retatrutide: The Triple Agonist Beyond Ozempic"
description: "Retatrutide targets three hormone receptors at once — here is what the early trial data says about weight loss, side effects, and when it may be available."
canonical: "https://www.vitalsvault.com/blog/retatrutide-triple-agonist-weight-loss-next-glp1"
last-updated: 2026-08-22
---

# Retatrutide: The Triple Agonist Beyond Ozempic

> Retatrutide targets three hormone receptors at once — here is what the early trial data says about weight loss, side effects, and when it may be available.

---

Canonical HTML: https://www.vitalsvault.com/blog/retatrutide-triple-agonist-weight-loss-next-glp1
- [llms.txt](https://www.vitalsvault.com/llms.txt)
- [sitemap.xml](https://www.vitalsvault.com/sitemap.xml)
- [Developer portal](https://www.vitalsvault.com/developers)